Experience: Thomas has more than 35 years of experience in various positions in international pharmaceutical industry, mainly in pharmaceutical manufacturing, development, company building and management in private and public companies
Current assignments: Founder and main owner of Flerie Invest AB. Chairman of the board of Amarna Therapeutics BV, NorthX Biologics AB and Prokarium Ltd, and a board member of Buzzard Pharmaceuticals AB, Chromafora AB, Flerie Invest AB, Kahr Bio Ltd, Nanologica AB, Toleranzia AB and Sixera Pharma AB, among others.
Previous assignments: Co-founder of Recipharm AB, where he served as CEO from 2008 to 2021.
Shareholding: 315,692,260 (via related party)
Independent in relation both to the Company and its management, but not independent to major shareholders.
